Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02514902 · ClinicalTrials.gov registry record · NA
Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)
A NA study, sponsored by Justin Fraser.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT02514902 is a NA study that has completed, run by Justin Fraser. The registered enrollment target is 48 participants.
The verdict
NCT02514902, a NA study, has completed, sponsored by Justin Fraser.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
In the search for a novel marker of stroke that could be rapidly assessed in blood, the investigators developed a point-of-care (POC) lateral flow device (LFD) that rapidly (\< 15 min) detects levels of a biomarker that is released into blood following neuronal injury associated with stroke and traumatic brain injury. The protein's expression in human brain should serve as a useful biomarker of neuronal injury in stroke and traumatic brain injury.
Interventions
- DEVICE Lateral Flow Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-03-25 |
| Est. Completion | 2016-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02514902
The ClinicalTrials.gov registry entry for NCT02514902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Justin Fraser, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lateral Flow Device is the first listed.
NCT02514902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02514902 about?
NCT02514902 is a clinical study titled "Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)". In the search for a novel marker of stroke that could be rapidly assessed in blood, the investigators developed a point-of-care (POC) lateral flow device (LFD) that rapidly (\< 15 min) detects levels of a biomarker that is released into blood following neuronal injury associated with stroke and trau...
What is the current status of trial NCT02514902?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2015-03-25. Estimated completion is 2016-12-16.
What interventions are being tested in trial NCT02514902?
The interventions under investigation include: Lateral Flow Device (DEVICE).
Who is sponsoring clinical trial NCT02514902?
This trial is sponsored by Justin Fraser, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.